Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02066233 · ClinicalTrials.gov registry record · NA
Prospective Study to Compare the Efficacy of E.G.Scan to Detect Barrett's Esophagus Compared With Standard Endoscopy
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT02066233: Completed NA study, sponsored by Mayo Clinic.
NCT02066233 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02066233, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
The purpose of this study was to evaluate whether a disposable nasal endoscope called "E.G. Scan II" will visualize the esophagus as well as the standard test, sedated endoscopy.
Interventions
- DEVICE EG Scan II (transnasal endoscopy)
- PROCEDURE Standard Endoscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2014-03 |
| Est. Completion | 2016-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02066233
The ClinicalTrials.gov registry entry for NCT02066233 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which EG Scan II (transnasal endoscopy) is the first listed.
NCT02066233 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02066233 about?
NCT02066233 is a clinical study titled "Prospective Study to Compare the Efficacy of E.G.Scan to Detect Barrett's Esophagus Compared With Standard Endoscopy". The purpose of this study was to evaluate whether a disposable nasal endoscope called "E.G. Scan II" will visualize the esophagus as well as the standard test, sedated endoscopy.
What is the current status of trial NCT02066233?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2014-03. Estimated completion is 2016-03.
What interventions are being tested in trial NCT02066233?
The interventions under investigation include: EG Scan II (transnasal endoscopy) (DEVICE), Standard Endoscopy (PROCEDURE).
Who is sponsoring clinical trial NCT02066233?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.